Paralyzed man walks again after experimental drug trial triggers remarkable recovery
An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom noted remarkable outcomes.Larry Williams, a trial participant based in Philadelphia, Pennsylvania, shared with Fox News Digital that he’s been able to walk again after an accident that caused paralysis.FOUR FAMILIES ARE DESPERATE TO RAISE FUNDS FOR THEIR CHILDREN’S […]
